| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Sanders Corazon (Corsee) D. | Director | C/O LEGEND BIOTECH CORP, 2101 COTTONTAIL LANE, SOMERSET | /s/ James Pepin, Attorney-in-Fact | 18 Mar 2026 | 0001796536 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | LEGN | Ordinary Shares | 59,115 | 18 Mar 2026 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | LEGN | Share Option (right to buy) | 18 Mar 2026 | Ordinary Shares | 12,000 | $11.50 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer. |
| F2 | Includes 25,674 restricted share units (the "RSUs"). Each RSU represents a contingent right to receive one ordinary share of the Issuer upon settlement. 7,136 RSUs have settled, with the remainder vesting (i) as to 2,100 RSUs, in 3 equal quarterly installments beginning on March 20, 2026, (ii) as to 5,888 RSUs, in 7 equal quarterly installments beginning on March 20, 2026, and (iii) as to 10,550 RSUs, with 25% of the shares vesting on June 20, 2026 with the remainder vesting 7 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer on each such vesting date. |
| F3 | All of the shares subject to the option are immediately exercisable. |
Exhibit 24 - Power of Attorney